Publications by authors named "Natalia Sarzi Sartorio"
Immunogenicity and Safety According to Immunosuppressive Drugs and Different COVID-19 Vaccine Platforms in Immune-Mediated Disease: Data from SAFER Cohort.
Ketty Lysie Libardi Lira Machado Ana Paula Neves Burian Olindo Assis Martins-Filho José Geraldo Mill Lunara Baptista Ferreira Natalia Sarzi Sartorio
Vaccines (Basel)
December 2024
Background/objectives: The effectiveness of COVID-19 vaccine in patients with immune-mediated inflammatory diseases (IMID) depends on the underlying disease, immunosuppression degree and the vaccine regimens. We evaluate the safety and immunogenicity of different COVID-19 vaccine schedules.
Methods: The SAFER study: "Safety and effectiveness of the COVID-19 Vaccine in Rheumatic Disease", is a Brazilian multicentric prospective observational phase IV study in the real-life.